HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Scintigraphic detection of breast cancer xenografts with Tc-99m natural and recombinant human alpha-fetoprotein.

Abstract
Because adenocarcinoma of the breast expresses receptors for alpha-fetoprotein (AFP), we studied Tc-99m AFP as a radiopharmaceutical to detect breast cancer. The biodistribution of Tc-99m radiolabeled natural human AFP (full length) and recombinant domain III (DIII) of human AFP was compared to Tc-99m sestamibi and Tl-201 in a murine model of human breast cancer. Estrogen receptor positive (MCF7, T-47D) and estrogen receptor negative (MDA-MB-231, BT-20) human breast cancer xenografts were grown subcutaneously in the lateral thorax region of immunosuppressed mice (ICR SCID). Quantitative comparisons of percent-injected dose per gram of tissue (%ID/gram) and tumor to thigh ratio (T/Th) were performed at 0-60 minutes and at 24 hours following injection. For most tumors, T/Th for AFP and DIII was significantly greater than T/Th for Tc-99m sestamibi and Tl-201. In all breast cancers (BT-20, MCF7, MDA-MB-231, T-47D), Tc-99m AFP T/Th increased from 60 minutes to 24 hours, suggesting good tumor retention of this radiopharmaceutical. DIII and AFP had significantly higher %ID/gram than either Tl-201 or Tc-99m sestamibi when considered across all tumor types at both 60 minutes and 24 hours. The data suggests that localization of Tc-99m AFP in human breast cancer xenografts is initially rapid, increases with time, and is superior to Tc-99m sestamibi and Tl-201. Given its high uptake by breast cancer cells, its low non-tumor localization and its rapid renal excretion, these Tc-99m AFP preparations may be useful agents to detect human breast carcinoma.
AuthorsB R Line, P J Feustel, S M Festin, T T Andersen, R N Dansereau, R L Lukasiewicz, S Zhu, J A Bennett
JournalCancer biotherapy & radiopharmaceuticals (Cancer Biother Radiopharm) Vol. 14 Issue 6 Pg. 485-94 (Dec 1999) ISSN: 1084-9785 [Print] United States
PMID10850335 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Radiopharmaceuticals
  • Receptors, Estrogen
  • Recombinant Proteins
  • Thallium Radioisotopes
  • alpha-Fetoproteins
  • Technetium
  • Technetium Tc 99m Sestamibi
Topics
  • Animals
  • Breast Neoplasms (diagnostic imaging)
  • Carcinoma, Hepatocellular
  • Female
  • Humans
  • Mice
  • Mice, Inbred ICR
  • Mice, SCID
  • Radionuclide Imaging
  • Radiopharmaceuticals (pharmacokinetics)
  • Receptors, Estrogen (analysis)
  • Recombinant Proteins (pharmacokinetics)
  • Technetium (pharmacokinetics)
  • Technetium Tc 99m Sestamibi (pharmacokinetics)
  • Thallium Radioisotopes
  • Tissue Distribution
  • Transplantation, Heterologous
  • Tumor Cells, Cultured
  • alpha-Fetoproteins (pharmacokinetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: